TCL Archive Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds August 26, 2005
TCL Archive GAO Probes NCI Intramural Program, Finds All Is Well, But Won’t Report It October 22, 1982
TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
